Portfolio
Advancing Portfolio
Screening project between Daiichi Sankyo RD Novare and TB Alliance
-
RFP Year2022
-
Awarded Amount$152,970DiseaseTuberculosisInterventionDrugDevelopment StageHit IdentificationCollaboration PartnersDaiichi Sankyo RD Novare Co., Ltd. , The Global Alliance for TB Drug Development